Hypoglycemia: Concomitant use with an insulin secretagogue or insulin may increase the risk of hypoglycemia, including severe hypoglycemia
iGlarLixi reduces glycated hemoglobin to a greater extent than basal insulin regardless of levels at screening: post hoc analysis of LixiLan-L
Hydration is essential for overall health as water plays a crucial role in many bodily functions
The weight scale paradox: why creatine makes your tirzepatide results look worse (temporarily) This trips up almost everyone
"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
Then here are some things you should know before you make the jump